Regency Centers (REG) Principal Accounting Officer granted 3,173 restricted shares

Rhea-AI Filing Summary

REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.

The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Devereaux Terah L

(Last) (First) (Middle)

ONE INDEPENDENT DRIVE

SUITE 114

(Street)

JACKSONVILLE FL 32202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Grant	(1)	03/04/2026		A		3,173		(1)	(1)	Common Stock	3,173	$0	3,173	D

Explanation of Responses:

1. Shares vest 25% per year beginning March 4, 2027.

Remarks:

	/s/Michael R. Herman Attorney-in-Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did REG reporting person Terah L. Devereaux report?

Terah L. Devereaux reported receiving a grant of 3,173 restricted stock shares. The award was recorded on March 4, 2026 and is classified as a grant or award acquisition, rather than an open-market purchase or sale, under Form 4 reporting rules.

How many Regency Centers (REG) shares were granted in this Form 4 filing?

The filing shows a grant of 3,173 restricted stock shares to Terah L. Devereaux. This entire amount was acquired in a single transaction, increasing the total number of reported directly owned shares related to this award to 3,173 after the transaction.

At what price were the REG restricted stock shares granted to Terah L. Devereaux?

The restricted stock grant is reported at a transaction price of $0.00 per share. This indicates the shares were awarded as equity compensation rather than bought in the market, consistent with a typical stock-based incentive arrangement for company officers.

How do the 3,173 REG restricted stock shares vest for Terah L. Devereaux?

According to the footnote, the 3,173 restricted stock shares vest 25% per year. Vesting begins on March 4, 2027, meaning the award becomes earned in four equal annual installments, subject to the stated vesting schedule and any applicable service conditions.

What is Terah L. Devereaux’s role at Regency Centers (REG) in this Form 4?

The reporting person, Terah L. Devereaux, is identified as an officer of Regency Centers with the title Principal Accounting Officer. The reported 3,173-share restricted stock grant reflects equity compensation associated with this officer position, as disclosed in the Form 4.

Is this REG Form 4 transaction a stock purchase or sale in the open market?

The transaction is classified as a grant or award acquisition, not an open-market trade. Code “A” and a $0.00 per-share price show these 3,173 shares were issued as restricted stock compensation rather than bought or sold on a stock exchange.